Click here to view online. Add this email to your safelist.
How AI and machine learning are augmenting our approach to drug discovery
26 February 2024
Machine learning is improving how we generate, screen and evaluate molecules as potential candidate medicines. By combining traditional chemistry high-throughput screening with AI and machine learning approaches, we are accelerating how we design, develop and make the next generation of therapeutics for patients.
|
|||||
|
|||||
|
For more information please visit astrazeneca.com. If you would like to unsubscribe please click here. |
